Cite
POS0697 OPHTHALMOLOGICAL ADVERSE EVENTS UNDER JAK: CASE ANALYSIS OF THE EUROPEAN PHARMACOVIGILANCE DATABASE
MLA
S. Hecquet, et al. “Pos0697 Ophthalmological Adverse Events under Jak: Case Analysis of the European Pharmacovigilance Database.” Annals of the Rheumatic Diseases, vol. 81, May 2022, p. 628.1-628. EBSCOhost, https://doi.org/10.1136/annrheumdis-2022-eular.3356.
APA
S. Hecquet, M. B. Rabier, M. Lepelley, M. Chouk, F. Verhoeven, C. Prati, & D. Wendling. (2022). Pos0697 Ophthalmological Adverse Events under Jak: Case Analysis of the European Pharmacovigilance Database. Annals of the Rheumatic Diseases, 81, 628.1-628. https://doi.org/10.1136/annrheumdis-2022-eular.3356
Chicago
S. Hecquet, M. B. Rabier, M. Lepelley, M. Chouk, F. Verhoeven, C. Prati, and D. Wendling. 2022. “Pos0697 Ophthalmological Adverse Events under Jak: Case Analysis of the European Pharmacovigilance Database.” Annals of the Rheumatic Diseases 81 (May): 628.1-628. doi:10.1136/annrheumdis-2022-eular.3356.